Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The weight loss effects of GLP-1-based therapies are particularly beneficial for obese patients with type 2 diabetes[^5^]
A recent study found the long-term program would have cost insurance companies billions of dollars in the first year
It was observed that the drugs caused an average weight loss of 15% to over 20% of body weight [8,9]
What the trial data shows about stopping The most-cited evidence on discontinuation comes from the extension phase of the STEP 1 trial, published in Diabetes, Obesity and Metabolism
Use Liquids Strategically Some patients tolerate liquid protein better while on GLP-1 medications
Fernandez, E., Wargo, J
US$ 22.40
US$ 27.01
US$ 20.24
US$ 23.38
